Fig. 6From: LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma MiR-302b-3p targets SLC2A4 and inhibits its expression directly. a Identification of the potential targets of miR-302b-3p using online prediction databases and qRT-PCR analysis. b The predicted binding site of miR-302b-3p within the SLC2A4 3’UTR. c The binding interaction between SNHG16 and miR-302b-3p was confirmed by luciferase reporter assay. d, e qRT-PCR and western blot analyses of the effect of miR-302b-3p on SLC2A4 expression. f, g Relative expression levels of SLC2A4 in PC tissues and cell lines. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page